Hempeatein Pro approved for sale in china by Hill Pharma – Owner of Leading Sport Nutritional products

Admin   |   12 December, 2014   |   283   |   3980

FAIRFIELD, NJ / ACCESSWIRE / December 11, 2014 / Hill Pharma Inc. announced today the approval in China of its next generation sport nutrition product Hempeatein Pro(TM) with ac-11(R).

Charles Dong, CEO of Hill Pharma Inc., said, "We dedicated substantial resources and man hours to expedite the approval process for Hempeatein Pro(TM) with ac-11(R). There is a demonstrated track record of support among Chinese consumers for innovative new products backed by science and we are confident that the established performance benefits of our plant-based proteins, combined with the scientific and clinically validated reparative qualities of ac-11(R) will become a favorite among active, health conscious Chinese adults. To reach these valued customers, we plan to target a host of selling channels, including retail and direct to consumer/MLM."

Tony Worth, Managing Director of Optigenex Inc., maker of ac-11(R), added, "We are excited to be entering the rapidly expanding market in China in partnership with a local company that enjoys a respected name among Chinese consumers. Hill Pharma's strong position in China will provide a solid platform for what we expect will be a very successful product launch."

Speaking about the new product, Mr. Worth continued, "Hempeatein Pro(TM) with ac-11(R) was specially formulated to enhance recovery following rigorous exercise and sports activity. The product is also uniquely designed to help athletes and other active people naturally increase lean muscle mass with a GMO free, organic, plant based protein product."